• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Is Screening for Asymptomatic Atrial Fibrillation Indicated?

Article

Undiagnosed AF was discovered in 3% of individuals; 2% of individuals with known AF who were not on oral anticoagulation were also identified.

Asymptomatic paroxysmal atrial fibrillation (AF), which occurs in approximately one-third of patients, poses an especially challenging dilemma. Such patients, who report no symptoms, and whose annual physical examination, including ECG findings, are normal, nonetheless carry a stroke risk as determined by the CHADS2 score.  Because oral anticoagulation is highly effective in preventing thromboembolism, screening high-risk populations (such as the elderly) may be beneficial. However, there is a paucity of data about whether such mass screening will reduce the incidence of stroke.

A recent randomized study by a Swedish group (STROKESTOP trial) presented at the European Society of Cardiology Congress in September 2013 reported that population-based screening of asymptomatic patients identified 5% of the population as candidates for oral anti-coagulation.  In this large study, 25,415 inhabitants (aged 75-76 years) of Stockholm County and the Region Halland (Sweden) were randomized in a 1:1 fashion to control versus AF screening, done with intermittent ECG recordings over two weeks.
 
During the10-month follow up, of those subjects in the screening arm, undiagnosed AF was discovered in 3% of individuals; 2% of individuals with known AF who were not on oral anticoagulation were also identified.  More than 90% of the newly-diagnosed AF patients were started on anticoagulation.

The STROKESTOP investigators plan to report prospective data with 5-year follow up and clinical outcomes.  However, the preliminary results of this study are encouraging that population-based screening may be an effective tool to identify additional candidates with AF for oral anticoagulation.  Whether this approach will translate into a decreased incidence of stroke in this population or prove to be cost-effective remains to be seen with longer follow-up.

Source:

Svennberg CE, Engdahl J, Frykman-Kull  V, Friberg L, Levin L. , Rosenqvist M. Preliminary results from the STROKESTOP trial on the mass screening for silent atrial fibrillation in high risk patients.  Presented at the European Society of Cardiology Congress 2013; September 3, 2013; Amsterdam, The Netherlands. 

Preliminary results from the STROKESTOP trial on the mass screening for silent atrial fibrillation in high risk patients. CardioValens.com. Accessed on September 11, 2013 and available at: http://www.cardiovalens.com/news/newsdisplay.asp?newsid=24239Stroke prevention by screening elderly for AF. ESC Congress News. Sunday, September 8, 2013
 

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.